Franseen Koob

1. Ua tiav cov kab ntau lawm, ntau tshaj 12 xyoo ntawm kev paub txog engineers thiab zoo -cov neeg ua haujlwm tau txais kev cob qhia.
2. Tag nrho cov khoom raug tsim thiab xa tawm nruj raws li ISO9001: 2015 tus qauv.
3. Ua kom tus nqi dhau mus rau 98 feem pua ntawm qhov siab tshaj plaws, thaum lub sij hawm tsim khoom luv luv li ntawm ib lub lis piam los muab cov neeg siv khoom zoo tshaj plaws thiab cov kev pabcuam.
4. Peb cov neeg muag khoom tau txawj sau ntawv thiab hais lus Askiv, thiab peb cov engineers tau hais sai sai hauv 6 teev.
5. Kev xa khoom sai thiab raws sijhawm, kev pabcuam ceev thiab kev tshaj lij.
6. Cov neeg siv khoom tuaj yeem siv cov kev them nyiaj hauv online xws li PAYPAL los them tus nqi qis me me kom luv luv cov qauv siv sijhawm.
7. Peb muaj kev koom tes ua lag luam zoo nrog cov neeg siv khoom sib txawv los ntawm ntau lub teb chaws.

Xa kev nug

Hauj lwm lawm

Khoom Specification

Cov khoom npe	Franseen koob
khoom	Stainless hlau, thiab lwm yam.
Koob Loj	12G, 14G, 16G, 18G, 19G, 20G, 21G, 22G, 23G, 25G, 26G, 30G, 31G, 32G
Cov khoom	Txhaj Puncture Instrument
Custom feature	Raws li koj 2D / 3D Drawing lossis qauv muab
Pob	Standard carton or according to customer's requirement
Ntawv pov thawj	ISO9001: 2015, SGS

Khoom Qhia

In this study, in order to prove true histological tissue procurement, we used specialised imaging software to quantify individual tissue components. Our observations proved that the study hypothesis was correct: the Franseen biopsy needle yielded high-quality histology samples significantly more often than the standard FNA needle. Histological architecture was retained, and the total tissue and tumour yield from the FNB needles were 20 and 7 times greater, respectively, than that procured using FNA needles from the same lesion. Furthermore, desmoplastic fibrosis was seen in 85 percent of FNB samples compared with only 33 percent in the FNA cohort. Desmoplasia is an expected cellular reaction to a neoplastic process but is difficult to procure using standard bevel FNA needles as it requires 'coring' of the tissue. This is particularly relevant in clinical trials because patients with pancreatic cancer with activated stroma tend to have a poor prognosis and are less likely to benefit from neoadjuvant therapy. Two of the 10 samples in this study tested positive for K-ras G12D mutation, which is an independent prognostic marker for advanced ductal adenocarcinoma with poor response to gemcitabine-based chemotherapeutic regimens. Chromium Endoscopic Biopsy Needle